Inhalation challenge with carbachol and isoproterenol to predict bronchospastic response to propranolol in COPD.

Abstract

Disabling propranolol-induced bronchospasm occasionally prevents use of this drug in patients with chronic obstructive pulmonary disease (COPD). A means was developed to identify patients who have high risk for this adverse effect using bronchial challenge by inhaling the parasympathomimetic drug, carbachol, and isoproterenol. After baseline pulmonary… (More)

Topics

Cite this paper

@article{Popio1983InhalationCW, title={Inhalation challenge with carbachol and isoproterenol to predict bronchospastic response to propranolol in COPD.}, author={K A Popio and Dennis H. Jackson and Mark J. Utell and Andrew J Swinburne and Richard W Hyde}, journal={Chest}, year={1983}, volume={83 2}, pages={175-9} }